Press
Personnel change on Else Kröner-Fresenius-Stiftung Management Board
Dr. Dr. Daniel Strech, Professor for Meta-Research and Translational Bioethics at the BIH QUEST Center of the Charité, to join the EKFS Management Board
Three new Else Kröner Clinician Scientist Professorships to advance research in pediatrics, anesthesiology, and hematology
EKFS provides long-term support to outstanding physicians with €1.1 million each
Else Kröner-Fresenius-Stiftung facilitates oncological care in Halle and Addis Ababa
New funding totaling 3 million euros for cancer care in Ethiopia and research in Germany
Neues Forschungsprojekt zur Pneumokokken-Impfung
Wissenschaftler:innen der Universitätsmedizin Mainz erforschen innovativen Ansatz zum Schutz gegen Pneumokokken-Erkrankungen
Mobile clinics bring healthcare to remote villages in India
2025 Else Kröner Fresenius Award for Development Cooperation in Medicine for Dipanwita Sarkar and the NGO ASHA, supported by German Doctors e. V.
Digital medicine in countries with limited resources: EKFS to fund innovative healthcare projects with 1.7 million euros
Support for four pioneering projects providing digital health solutions
GMP funding to support development of innovative medicinal products
4.7 million euros for six projects on GMP production of clinical trial material
RNA-based therapies: Hope for previously incurable diseases like Huntington’s disease
Anastasia Khvorova receives Else Kröner Fresenius Prize for Medical Research during celebratory event marking Else Kröner’s 100th birthday
Felix Burda Award 2025: Research team around Prof. Jakob N. Kather honored for AI project on colorectal cancer prognosis
More precise diagnoses, better therapies: Using artificial intelligence, a research team at TU Dresden aims to significantly improve the chances of colorectal cancer patients and receives the renowned Felix Burda Award. The research team has developed a deep learning model that evaluates tissue samples and creates individual risk profiles. This helps physicians to better predict the progression of colorectal cancer in patients, allowing for more personalized and precise treatment.
New funding program to attract US-based medical researchers
Else Kröner-Fresenius Stiftung to make €10 million available to German universities in 2025